Intermediate outcomes in randomized clinical trials: An introduction

Trials

Volumn 14, Issue 1, 2013, Pages

  Seuc, Armando H ^a   Peregoudov, Alexander ^a   Betran, Ana Pilar ^a   Gulmezoglu, Ahmet Metin ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Causal effects; Intention to treat approach; Intermediate outcomes; Principal stratification

Indexed keywords

CALCIUM;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HIGH RISK PATIENT; HUMAN; MEDICAL RESEARCH; PREECLAMPSIA; PREGNANT WOMAN; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STRATIFIED SAMPLE; TREATMENT INDICATION; TREATMENT OUTCOME;

CALCIUM; DIETARY SUPPLEMENTS; ENDPOINT DETERMINATION; FEMALE; HUMANS; INTENTION TO TREAT ANALYSIS; MEDICATION ADHERENCE; PRE-ECLAMPSIA; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84875031562     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-14-78     Document Type: Article

References (33)

1. Rochon J. Issues in adjusting for covariates arising postrandomization in clinical trials. Drug Information Journal 1999, 33:1219-1228.
2. Robins J. The control of confounding by intermediate variables. Stat Med 1989, 8:679-701. 10.1002/sim.4780080608, 2749074.
3. Robins J, Greenland S. Identifiability and exchangeability for direct and indirect effects. Epidemiology 1992, 3:143-155. 10.1097/00001648-199203000-00013, 1576220.
4. Little R, Rubin D. Causal effects in clinical and epidemiological studies via potential outcomes: Concepts and Analytical Approaches. Annu Rev Public Health 2000, 21:121-145. 10.1146/annurev.publhealth.21.1.121, 10884949.
5. Frangakis CE, Rubin D. Principal stratification in causal inference. Biometrics 2002, 58:21-29. 10.1111/j.0006-341X.2002.00021.x, 11890317.
6. Pan African Clinical Trials Registry [Internet]: South African Cochrane Centre, P.O. Box 19070, Tygerberg, 7505. South Africa Identifier PACTR201105000267371, WHO randomized trial of calcium supplementation before pregnancy to reduce recurrent preeclampsia. 2010, Dec 6 [cited 2012 March 3]; [8 screens]. [http://www.pactr.org/ATMWeb/appmanager/atm/atmregistry?da=true&tno=PACTR201105000267371], Pan African Clinical Trials Registry [Internet]: South African Cochrane Centre, P.O. Box 19070, Tygerberg, 7505. South Africa.
7. Gunasekara FI, Carter K, Blakely T. Glossary for econometrics and epidemiology. J Epidemiol Community Health 2008, 62:858-861. 10.1136/jech.2008.077461, 18791041.
8. Rothman KJ, Greenland S. Modern Epidemiology 1998, Philadelphia: Lippincott-Raven, 2.
9. Brookhart MA, Rassen JA, Schneeweiss S. Instrumental variable methods in comparative safety and effectiveness research. Effective Health Care Research Report No. 22. (Prepared by Brigham and Women's Hospital DEcIDE Center Under Contract No. 290-2005-0016I T03) 2010, Rockville, MD: Agency for Healthcare Research and Quality, [http://effectivehealthcare.ahrq.gov/reports/final.cfm].
10. Angrist JD, Imbens GW. Two-stage least squares estimation of average causal effects in models with variable treatment intensity. J Am Stat Assoc 1995, 90:431-442.
11. Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol 2000, 29:722-729. 10.1093/ije/29.4.722, 10922351.
12. Rassena JA, Brookhart MA, Glynna RJ, Mittleman MA, Schneeweiss S. Instrumental variables I: instrumental variables exploit natural variation in nonexperimental data to estimate causal relationships. J Clin Epidemiol 2009, 62:1226-1232. 10.1016/j.jclinepi.2008.12.005, 2905668, 19356901.
13. MacPherson H. Pragmatic clinical trials. Complement Ther Med 2004, 12:136-140. 10.1016/j.ctim.2004.07.043, 15561524.
14. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 1999, 319:670. 10.1136/bmj.319.7211.670, 28218, 10480822.
15. Stuart EA, Perry DF, Le H-N, Ialongo NS. Estimating intervention effects of prevention programs: Accounting for noncompliance. Prev Sci 2008, 9:288-298. 10.1007/s11121-008-0104-y, 2921838, 18843535.
16. Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database of Systematic Reviews 2010, (8):CD001059.
17. Belizan JM, Villar J, Gonzalez L, Campodonico L, Bergel E. Calcium supplementation to prevent hypertensive disorders of pregnancy. N Engl J Med 1991, 325:1399-1405. 10.1056/NEJM199111143252002, 1922250.
18. Levine RJ, Hauth JC, Curet LB, Sibai BM, Catalano PM, Morris CD, DerSimonian R, Esterlitz JR, Raymond EG, Bild DE, Clemens JD, Cutler JA. Trial of calcium to prevent preeclampsia. N Engl J Med 1997, 337:69-76. 10.1056/NEJM199707103370201, 9211675.
19. Villar J, Abdel-Aleem H, Merialdi M, Mathai M, Ali M, Zavaleta N, Purwar M, Hofmeyr J, Nguyen TN, Campódonico L, Landoulsi S, Carroli G, Lindheimer M, . World Health Organization Calcium Supplementation for the Prevention of Preeclampsia Trial Group World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol 2006, 194:639-649. 10.1016/j.ajog.2006.01.068, 16522392, World Health Organization Calcium Supplementation for the Prevention of Preeclampsia Trial Group.
20. Sanchez-Ramos L, Briones DK, Kaunitz AM, Delvalle GO, Gaudier FL, Walker KD. Prevention of pregnancy-induced hypertension by calcium supplementation in angiotensin II sensitive patients. Obstet Gynecol 1994, 84:349-353.
21. Frumento P, Fabrizia M, Barbara P, Rubin DB. Forthcoming. Evaluating the effect of training on wages in the presence of noncompliance, nonemployment, and missing outcome data. Journal of the American Statistical Union accessed November 2012). [http://nrs.harvard.edu/urn-3:HUL.InstRepos:9275635].
22. Barnard J, Frangakis CE, Hill JL, Rubin DB. Principal stratification approach to broken randomized experiments: a case study of school choice vouchers in New York City. J Am Stat Assoc 2003, 98:462.
23. Yau LHY, Little RJ. Inference for the complier-average causal effect from longitudinal data subject to noncompliance and missing data, with application to a job training assessment for the unemployed. J Am Stat Assoc 2001, 96:456.
24. Rubin D. Causal inference using potential outcomes: design, modeling, decisions. J Am Stat Assoc 2005, 100:469.
25. Rubin D. Causal inference through potential outcomes and principal stratification: application to studies with " censoring" due to death. Stat Sci 2006, 21:299-309.
26. Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables. J Am Statist Ass 1996, 91:444-455.
27. Dunn G, Maracy M, Tomenson B. Estimating treatment effects from randomized clinical trials with noncompliance and loss to follow-up: the role of instrumental variable methods. Stat Methods Med Res 2005, 14:369-395. 10.1191/0962280205sm403oa, 16178138.
28. Imbens GW, Rubin DB. Bayesian Inference for Causal Effects in Randomized Experiments with Noncompliance. Ann Stat 25:305-327.
29. Frangakis CE, Varadhan R. Systematizing the evaluation of partially controlled studies using principal stratification: from theory to practice. Stat Sin 2004, 14:945-947.
30. Altman DG. Missing outcomes in randomized trials: addressing the dilemma. Open Medicine 2009, 3:2.
31. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010, 340:c869. 10.1136/bmj.c869, 2844943, 20332511.
32. Godwin M, Ruhland L, Casson I, MacDonald S, Delva D, Birtwhistle R, Lam M, Seguin R. Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity. BMC Med Res Methodol 2003, 3:28. 10.1186/1471-2288-3-28, 317298, 14690550.
33. Rubin DB. Bayesian inference for causal effects: the role of randomization. Ann Statist 1978, 6:34-58.